Correlation Between Palisade Bio and LMF Acquisition
Can any of the company-specific risk be diversified away by investing in both Palisade Bio and LMF Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Palisade Bio and LMF Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Palisade Bio and LMF Acquisition Opportunities, you can compare the effects of market volatilities on Palisade Bio and LMF Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Palisade Bio with a short position of LMF Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of Palisade Bio and LMF Acquisition.
Diversification Opportunities for Palisade Bio and LMF Acquisition
-0.03 | Correlation Coefficient |
Good diversification
The 3 months correlation between Palisade and LMF is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Palisade Bio and LMF Acquisition Opportunities in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LMF Acquisition Oppo and Palisade Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Palisade Bio are associated (or correlated) with LMF Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LMF Acquisition Oppo has no effect on the direction of Palisade Bio i.e., Palisade Bio and LMF Acquisition go up and down completely randomly.
Pair Corralation between Palisade Bio and LMF Acquisition
Given the investment horizon of 90 days Palisade Bio is expected to under-perform the LMF Acquisition. But the stock apears to be less risky and, when comparing its historical volatility, Palisade Bio is 1.02 times less risky than LMF Acquisition. The stock trades about -0.22 of its potential returns per unit of risk. The LMF Acquisition Opportunities is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 204.00 in LMF Acquisition Opportunities on December 27, 2024 and sell it today you would earn a total of 16.00 from holding LMF Acquisition Opportunities or generate 7.84% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Palisade Bio vs. LMF Acquisition Opportunities
Performance |
Timeline |
Palisade Bio |
LMF Acquisition Oppo |
Palisade Bio and LMF Acquisition Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Palisade Bio and LMF Acquisition
The main advantage of trading using opposite Palisade Bio and LMF Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Palisade Bio position performs unexpectedly, LMF Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LMF Acquisition will offset losses from the drop in LMF Acquisition's long position.Palisade Bio vs. Zura Bio Limited | Palisade Bio vs. Immix Biopharma | Palisade Bio vs. Enveric Biosciences | Palisade Bio vs. ZyVersa Therapeutics |
LMF Acquisition vs. ZyVersa Therapeutics | LMF Acquisition vs. Sonnet Biotherapeutics Holdings | LMF Acquisition vs. Revelation Biosciences | LMF Acquisition vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Stocks Directory Find actively traded stocks across global markets | |
CEOs Directory Screen CEOs from public companies around the world | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |